1. Hoffmann F, Glaeske G, Pfannkuche MS. The effect of introducing rebate contracts to promote generic drug substitution, on doctors' prescribing practices. Dtsch Arztebl Int. 2009;106(48):783–8. [Pubmed] [PMC Free Fulltext] |
|
2. World Health Organization. Generic Drugs. Geneva: WHO, 2016. Available at: http://www.who.int/trade/glossary/story034/en/(last accessed on January 20, 2016). |
|
3. King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croat Med J. 2002;43(4):462–9. [Pubmed] |
|
4. Rodin HA, Heaton AH, Wilson AR, Garrett NA, Plocher DW. Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit. Amer J Manag Care. 2009;15(12):881–8. [Pubmed] |
|
5. World Health Organization. The Pursuit of Responsible Use of Medicines: Sharing and Learning from Country Experiences Geneva: WHO, 2016. [Available at: http://www.who.int/medicines/areas/rational_use/en/(last accessed on January 21, 2016). |
|
6. Sharma P, Kumar S, Pahwa R, Sharma A. Opportunities for generic drugs in India. Int J Third World Med. 2008;8(1):1–5. |
|
7. Tata Strategic Management Group. Overview of Indian Pharmaceutical Industry, Asia Business Generator Project. Mumbai: Tata Strategic Management Group, 2016. Available at: http://www.ibpcosaka.or.jp/network/e_abg/e_india_abg_pharmacy_report200803.pdf (last accessed on January 21, 2016). |
|
8. Chaudhari M, Charan J. Prescription of generic drugs. Natl J Physiol Pharm Pharmacol. 2013;3(1):1–3. [DOI via Crossref] |
|
9. Kahook MY, Fechtner RD, Katz LJ, Noecker RJ, Ammar DA. A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatography-tandem mass spectrometry. Curr Eye Res. 2012;37(2):101–8. [DOI via Crossref] [Pubmed] |
|
10. Decollogny A1, Eggli Y, Halfon P, Lufkin TM. Determinants of generic drug substitution in Switzerland. BMC Health Serv Res. 2011;11:17. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|
11. Creative Research Calculator 2016. Sample Size Calculator Available at: http://www.surveysystem.com/sscalc.htm(last accessed on January 31, 2016). |
|
12. Jamshed SQ, Hassali MAA, Ibrahim MIM, Babar Z u D. Knowledge attitude and perception of dispensing doctors regarding generic medicines in Karachi, Pakistan: a qualitative study. J Pak Med Assoc. 2011;61(1):80–3. [Pubmed] |
|
13. Hassali MA, Kong DCM, Stewart K. Generic medicines: perceptions of general practitioners in Melbourne, Australia. J Generic Med. 2006;3(3):214–25. [DOI via Crossref] |
|
14. Sharrad AK, Hassali MA, Shafie AA. Generic medicines: perceptions of physicians in Basrah, Iraq. Australas Med J. 2009;1(8):58–64. |
|
15. Chua GN, Hassali MA, Shafie AA, Awaisu A. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. Health Policy. 2010;95(2–3):229–35. [DOI via Crossref] [Pubmed] |
|
16. Dickov VT, Mitrovic D, Kuzman BM. Analyzing pharmaceutical industry. Natl J Physiol Pharm Pharmacol. 2011;1(1):1–8. [DOI via Crossref] |
|
17. Kingman S. Fisons investigations of excessive hospitality. Br Med J. 1993;307:1301–2. [Pubmed] |
|
18. Kersnik J, Peklar J. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies. J Clin Pharm Ther. 2006;31(6):577–83. [DOI via Crossref] [Pubmed] |
|
19. Hsu YH, Fang W, Lee Y. Ethically questionable behavior in sales representatives—an example from the Taiwanese pharmaceutical industry. J Bus Ethics. 2009;88(0):155–66. [DOI via Crossref] |
|
20. Komesaroff PA, Kerridge IH. Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry. Med J Aust. 2002;176:118–21. [Pubmed] |
|
21. Prosser H, Almond S, Walley T. Influences on GPs' decision to prescribe new drugs—the importance of who says what. Fam Pract. 2003;20(1):61–8. [DOI via Crossref] [Pubmed] |
|
22. Caudill TS, Johnson MS, Rich EC, McKinney WP. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med. 1996;5(4):201–6. [DOI via Crossref] [Pubmed] |
|
23. Rohra DK, Gilani AH, Memon IK, Perven G, Khan MT, Zafar H, et al. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan. J Pharm Pharm Sci. 2006;9(1):50–9. [Pubmed] |
|
24. Carthy P, Harvey I, Brawn R, Watkins C. A study of factors associated with cost and variation in prescribing among GPs. Fam Pract. 2000;17(1):36–41. [DOI via Crossref] [Pubmed] |
|
25. Peay ER, Peay MY. Differences among practitioners in patterns of preference for information sources in the adoption of new drugs. Soc Sci Med. 1984;18(12):1019–25. [DOI via Crossref] |
|
26. Andersson SJ, Lindberg G, Troein M. What shapes GPs' work with depressed patients? A qualitative interview study. Fam Pract. 2002;19(6):623–31. [DOI via Crossref] [Pubmed] |
|